This is the intended therapeutic benefit from the medicinal administration of afamelanotide
Medically reviewed by Alan Lucks | MD , Alan Lucks MDPC Private Practice - New York on October 24th, 2025
The company said in a statement that it wants patients in the US to only have access to "FDA-approved, safe, and effective" semaglutide products, adding: "These drugs are inherently complex to compound safely, and the risks they pose to patient safety far outweigh any benefits." The Alliance for Pharmacy Compounding (APC), a trade organisation representing the compounding industry, has claimed that Novo Nordisk is "confusing the fact that the semaglutide molecule is demonstrably difficult to manufacture [] with the relative simplicity of compounding with it," according to Reuters
In simple terms, GLP-1 helps regulate how much and when you eat, as well as how your body processes foodespecially carbohydrates (Bodnaruc et al 2016
A walk, a good brisk walk is good
